Caris Biopharma Partnering

Inform and Empower your Precision Oncology Programs

Have Confidence Caris will Provide You with the Complete Picture

Caris Biopharma leverages leading molecular science and artificial intelligence to help drive the development and commercialization of new therapies.

Precision Biopharma Partnering

Delivering value across the full life cycle of biopharma therapeutics

INFORM with insights from the industry’s most comprehensive clinico-genomic database

 

EMPOWER through Precision Partnering with customizable offerings

  • An answer for both sample types: tissue or blood
  • One platform for clinical trials and real-world data
  • State-of-the-art equipment and facilities
  • Global regulatory and commercial capabilities
round_graphic37.svg

Caris Discovery

Identifying novel therapeutic targets in oncology is a critical unmet need. Our proprietary end-to-end discovery platform coupled with deep genomic and matched clinical information will enhance our ability to identify and validate clinically relevant novel targets.

  • Robust in-silico and wet lab tools to characterize and validate targets, including proprietary technologies.
  • Real-world patient level data to help partners understand the clinical relevance of targets and make early program decisions regarding where to invest and how to optimize.
  • Modality agnostic platforms that can be tailored to a specific modality depending on partner needs.

Learn more about Caris’ unparalleled data, innovation lab, and broad footprint to help you unlock otherwise inaccessible target discovery opportunities.

Clinical Development

Caris solutions provide assurance to your development programs by supporting data-driven decisions. Unmatched breadth and depth of profiling coverage from a single platform enables a seamless transition from clinical trial data to real world applications.

  • WTS, WES profiling allows you to evolve when science evolves
  • RWE projects support decision making
  • MI Trials offering accelerates enrollment by identifying biomarker+ patients from our extensive network of clinical sites, with the support of our dedicated oncology nurse navigators

See how Caris solutions can help accelerate development timeline, maximize program potential, and navigate complexities.

Biopharma Commercialization

Enable the future of precision medicine with a platform built to last.

  • Co-partnership provides an optimal approach of developing, validating and launching your novel CDx biomarker
  • Comprehensive tests and associated services enable the development of multigene signatures and complex biomarkers
  • Established Caris commercial reach can seamlessly bridge clinical investigations and global launches
  • MI Insights: Biomarker-based alert system for therapeutic commercial success
  • Opportunity for coordinated market access and medical education initiatives

Learn how co-partnership provides an optimal approach of developing, validating and launching your novel CDx biomarker.

Dedicated Biopharma Teams for You

Our partners are our priority because we want to help you deliver on the promise of precision oncology

biopharma-experienced-teams-hex-3-1.png
  • Diverse experience across biopharma and diagnostic industry
  • Expertise in molecular science, clinical development, medical affairs, CDx and commercial
  • Thought partnership with our internal experts in medical, bioinformatics, translational medicine, and regulatory
  • Passionate and engaged team tailored for each partner
biopharma-matched-profiles-hex

MATCHED CLINICO-GENOMIC PROFILES


biopharma-residual-slides-hex-1.png

RESIDUAL
FFPE
SLIDES


biopharma-partnerships-hex-1.png

BIOPHARMA PARTNERSHIPS SINCE 2021


biopharma-partner-therapeutics-hex-1.png

PARTNER THERAPUETICS EMPOWERD BY CARIS


Contact Us

"*" indicates required fields

Name*
Preferred contact method*
Best time to contact
: